Works matching AU Samplonius, Douwe F.

Results: 26

Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.

Published in:

Lasers in Surgery & Medicine, 2014, v. 46, n. 8, p. 650, doi. 10.1002/lsm.22281

By:

Peng, Wei;
Samplonius, Douwe F.;
de Visscher, Sebastiaan;
Roodenburg, Jan. L. N.;
Helfrich, Wijnand;
Witjes, Max J.H.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
Waarde, Aren van;
O Dierckx, Rudi A. J.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, W.;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells.

Published in:

Journal of Investigative Dermatology, 2012, v. 132, n. 9, p. 2302, doi. 10.1038/jid.2012.133

By:

Wiersma, Valerie R;
de Bruyn, Marco;
van Ginkel, Robert J;
Sigar, Emily;
Hirashima, Mitsuomi;
Niki, Toshiro;
Nishi, Nozomu;
Samplonius, Douwe F;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activity.

Published in:

British Journal of Haematology, 2014, v. 164, n. 2, p. 304, doi. 10.1111/bjh.12617

By:

Wiersma, Valerie R.;
He, Yuan;
Samplonius, Douwe F.;
Ginkel, Robert J.;
Gerssen, Jurjen;
Eggleton, Paul;
Zhou, Jin;
Bremer, Edwin;
Helfrich, Wijnand

Publication type:

Article

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET.

Published in:

EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00155-2

By:

Helbert, Hugo;
Ploeg, Emily M.;
Samplonius, Douwe F.;
Blok, Simon N.;
Antunes, Ines F.;
Böhmer, Verena I.;
Luurtsema, Gert;
Dierckx, Rudi A. J. O.;
Feringa, Ben L.;
Elsinga, Philip H.;
Szymanski, Wiktor;
Helfrich, Wijnand

Publication type:

Article

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selectively eliminate carcinoma cells.

Published in:

OncoImmunology, 2023, v. 12, n. 1, p. 1, doi. 10.1080/2162402X.2023.2207868

By:

Britsch, Isabel;
van Wijngaarden, Anne P.;
Ke, Xiurong;
Hendriks, Mark. A.J.M.;
Samplonius, Douwe F.;
Ploeg, Emily M.;
Helfrich, Wijnand

Publication type:

Article

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPa axis.

Published in:

OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.2005344

By:

Hendriks, Mark A. J. M.;
Britsch, Isabel;
Xiurong Ke;
van Wijngarden, Anne P.;
Samplonius, Douwe F.;
Ploeg, Emily M.;
Helfrich, Wijnand

Publication type:

Article

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.

Published in:

OncoImmunology, 2020, v. 9, n. 1, p. 1, doi. 10.1080/2162402X.2020.1824323

By:

Hendriks, Mark A. J. M.;
Ploeg, Emily M.;
Koopmans, Iris;
Britsch, Isabel;
Ke, Xiurong;
Samplonius, Douwe F.;
Helfrich, Wijnand

Publication type:

Article

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint.

Published in:

OncoImmunology, 2018, v. 7, n. 8, p. 1, doi. 10.1080/2162402X.2018.1466016

By:

Koopmans, Iris;
Hendriks, Djoke;
Samplonius, Douwe F.;
van Ginkel, Robert J.;
Helfrich, Wijnand;
Heskamp, Sandra;
Wierstra, Peter J.;
Bremer, Edwin

Publication type:

Article

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab.

Published in:

OncoImmunology, 2018, v. 7, n. 2, p. N.PAG, doi. 10.1080/2162402X.2017.1386361

By:

van Bommel, Peter E.;
He, Yuan;
Schepel, Ilona;
Hendriks, Mark A. J. M.;
Wiersma, Valerie R.;
van Ginkel, Robert J.;
van Meerten, Tom;
Ammatuna, Emanuele;
Huls, Gerwin;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.

Published in:

OncoImmunology, 2016, v. 5, n. 8, p. 1, doi. 10.1080/2162402X.2016.1202390

By:

Hendriks, Djoke;
He, Yuan;
Koopmans, Iris;
Wiersma, Valerie R.;
van Ginkel, Robert J.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

CD20 T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.999536

By:

de Bruyn, Marco;
Wouters, Maartje C A;
Klip, Harry G;
Nijman, Hans W;
Wiersma, Valerie R;
Samplonius, Douwe F;
Helfrich, Wijnand;
Bremer, Edwin;
Eggleton, Paul

Publication type:

Article

Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of 18F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 47, p. 10871, doi. 10.1002/chem.202001795

By:

Böhmer, Verena I.;
Szymanski, Wiktor;
Berg, Keimpe‐Oeds;
Mulder, Chantal;
Kobauri, Piermichele;
Helbert, Hugo;
Born, Dion;
Reeβing, Friederike;
Huizing, Anja;
Klopstra, Marten;
Samplonius, Douwe F.;
Antunes, Ines F.;
Sijbesma, Jürgen W. A.;
Luurtsema, Gert;
Helfrich, Wijnand;
Visser, Ton J.;
Feringa, Ben L.;
Elsinga, Philip H.

Publication type:

Article

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux.

Published in:

Autophagy, 2015, v. 11, n. 8, p. 1373, doi. 10.1080/15548627.2015.1063767

By:

Wiersma, Valerie R;
de Bruyn, Marco;
Wei, Yunwei;
van Ginkel, Robert J;
Hirashima, Mitsuomi;
Niki, Toshiro;
Nishi, Nozomu;
Zhou, Jin;
Pouwels, Simon D;
Samplonius, Douwe F;
Nijman, Hans W;
Eggleton, Paul;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells.

Published in:

Journal of Molecular Medicine, 2008, v. 86, n. 8, p. 909, doi. 10.1007/s00109-008-0348-9

By:

Bremer, Edwin;
De Bruyn, Marco;
Samplonius, Douwe F.;
Bijma, Theo;
Ten Cate, Bram;
De Leij, Lou F. M. H.;
Helfrich, Wijnand

Publication type:

Article

Galectin-9 Activates and Expands Human T-Helper 1 Cells

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0065616

By:

Gooden, Marloes J. M.;
Wiersma, Valerie R.;
Samplonius, Douwe F.;
Gerssen, Jurjen;
van Ginkel, Robert J.;
Nijman, Hans W.;
Hirashima, Mitsuomi;
Niki, Toshiro;
Eggleton, Paul;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members.

Published in:

Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-13530-w

By:

He, Yuan;
van Bommel, Peter E.;
Samplonius, Douwe F.;
Bremer, Edwin;
Helfrich, Wijnand

Publication type:

Article

C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.

Published in:

mAbs (1942-0862), 2015, v. 7, n. 2, p. 321, doi. 10.1080/19420862.2015.1007811

By:

Wiersma, Valerie R;
de Bruyn, Marco;
Shi, Ce;
Gooden, Marloes JM;
Wouters, Maartje CA;
Samplonius, Douwe F;
Hendriks, Djoke;
Nijman, Hans W;
Wei, Yunwei;
Zhou, Jin;
Helfrich, Wijnand;
Bremer, Edwin

Publication type:

Article

Works matching AU Samplonius, Douwe F.

Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells.

A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activity.

A proof-of-concept study on the use of a fluorescein-based <sup>18</sup>F-tracer for pretargeted PET.

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selectively eliminate carcinoma cells.

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPa axis.

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint.

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab.

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.

CD20 T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer.

Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of <sup>18</sup>F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging.

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux.

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells.

Galectin-9 Activates and Expands Human T-Helper 1 Cells

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members.

C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.